Systematic review / meta-analysis / 2019
Metformin use in patients with diabetes was linked to significantly lower vitamin B12 levels and a higher risk of vitamin B12 deficiency.
A meta-analysis of 31 studies evaluated associations between metformin use and vitamin B12 levels, anemia, and neuropathy in diabetic patients. Compared to non-users, metformin users had a significantly higher risk of vitamin B12 deficiency (RR 2.09; 95% CI 1.49, 2.93; P < 0.0001) and significantly lower serum vitamin B12 concentrations (MD -63.70 pM; 95% CI -74.35, -53.05; P < 0.00001), which depended on dose and duration. Metformin was also linked to a greater percentage decrease in serum vitamin B12 from baseline (MD -14.68%; 95% CI -17.98%, -11.39%; P < 0.00001), but no significant association was observed with anemia or neuropathy prevalence.
Shows an association, not proof of cause and effect.
- Study type
- Meta-analysis
- Who was studied
- Patients with diabetes across 31 included studies
- What was measured
- Vitamin B12 deficiency risk, serum vitamin B12 concentrations, anemia, and neuropathy
THE PAPER
Associations between metformin use and vitamin B12 levels, anemia, and neuropathy in patients with diabetes: a meta-analysis.
Yang W, Cai X, Wu H, Ji L. J Diabetes, 2019.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.